Free Trial

Cellebrite DI (CLBT) Earnings Date, Estimates & Call Transcripts

Cellebrite DI logo
$19.18 +0.11 (+0.58%)
As of 01:34 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cellebrite DI Latest Earnings Summary

Latest Q4 2024
Earnings Date
Feb. 13Estimated
Actual EPS
(Feb. 13)
$0.07 Missed By -$0.03
Consensus EPS
(Feb. 13)
$0.10

Cellebrite DI announced Q4 2024 earnings on February 13, 2025, reporting an EPS of $0.07, which missed analysts' consensus estimates of $0.10 by $0.03. With a trailing EPS of -$1.39, Cellebrite DI's earnings are expected to grow 20.00% next year, from $0.30 to $0.36 per share.

Get Cellebrite DI Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cellebrite DI and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CLBT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLBT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cellebrite DI Analyst EPS Estimates

Current Year EPS Consensus Estimate:$0.30 EPS
Next Year EPS Consensus Estimate: $0.36 EPS

Cellebrite DI Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/13/2025Q4 2024$0.10$0.07 -$0.03$0.08$107.26M-
11/6/2024Q3 2024$0.09$0.14+$0.05$1.21$102.06M$106.90M
8/15/2024Q2 2024$0.08$0.10+$0.02$0.32$91.94M$95.70M
5/23/2024Q1 2024$0.06$0.08+$0.02$0.52$85.34M$89.60M
2/15/2024Q4 2023$0.06$0.08+$0.02$0.24$85.43M$93.01M
11/14/2023Q3 2023$0.01$0.09+$0.08$0.15$82.13M$84.20M
8/8/2023Q2 2023$0.03$0.05+$0.02$0.27$72.52M$76.70M
5/10/2023Q1 2023$0.03$0.03-$0.27$69.42M$71.23M

Cellebrite DI Earnings - Frequently Asked Questions

Cellebrite DI (NASDAQ:CLBT) last announced its quarterly earning data on Thursday, February 13, 2025. Learn more on CLBT's earnings history.

Cellebrite DI updated its first quarter 2025 earnings guidance on Thursday, February, 13th. The company issued revenue guidance of $107.0 million-$112.0 million, compared to the consensus revenue estimate of $105.5 million.

In the previous quarter, Cellebrite DI (NASDAQ:CLBT) missed the analysts' consensus estimate of $0.10 by $0.03 with a reported earnings per share (EPS) of $0.07. Learn more on analysts' earnings estimate vs. CLBT's actual earnings.

The conference call for Cellebrite DI's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Cellebrite DI's latest earnings report can be read online.
Read Transcript

Cellebrite DI (NASDAQ:CLBT) has a recorded annual revenue of $401.20 million.

Cellebrite DI (NASDAQ:CLBT) has a recorded net income of -$283.01 million. CLBT has generated -$1.39 earnings per share over the last four quarters.

Cellebrite DI (NASDAQ:CLBT) has a forward price-to-earnings ratio of 63.80. The price/earnings-to-growth ratio is 4.4.

Cellebrite DI's earnings are expected to grow from $0.30 per share to $0.36 per share in the next year, which is a 20.00% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:CLBT) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners